Clinical Trial Update: A Multicenter Selective Screening Study to Investigate the Frequency of Neuronal Ceroid Lipofuxinosis Type 2 (CLN2)

View source ↗

Summary

A multicenter screening study is planned to determine the frequency of neuronal ceroid lipofuscinosis type 2 (CLN2). The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuronal Ceroid Lipofuscinosis Type

Snippet

Sponsor: Nadir Hastalıkları Araştırma Derneği | Conditions: Neuronal Ceroid Lipofuxinosis Type2 (CLN2) | Status: RECRUITING